Frontiers
US$ 28.51
glp-1 drugs sleep apnea Survey: Providers Want GLP-1s Approved for FDA approves weight loss drug
Description
doi: 10.1016/S2213-8587(20)30117-0
Patient acceptance also plays a critical role
For comparison there is a recent large retrospective cohort study (2) that uses deidentified data on patients from 66 different health care organizations
The Future The future is bright for GLP-1 agonists and their close relatives
GLP-1 inhibits PKC2 phosphorylation to improve the osteogenic differentiation potential of hPDLSCs in the AGE microenvironment
